Molecular basis for insulin fibril assembly
In the rare medical condition termed injection amyloidosis, extracellular fibrils of insulin are observed. We found that the segment of the insulin B-chain with sequence LVEALYL is the smallest segment that both nucleates and inhibits the fibrillation of full-length insulin in a molar ratio-dependent manner, suggesting that this segment is central to the cross-{beta} spine of the insulin fibril. In isolation from the rest of the protein, LVEALYL forms microcrystalline aggregates with fibrillar morphology, the structure of which we determined to 1 {angstrom} resolution. The LVEALYL segments are stacked into pairs of tightly interdigitated {beta}-sheets, each pair displaying the dry steric zipper interface typical of amyloid-like fibrils. This structure leads to a model for fibrils of human insulin consistent with electron microscopic, x-ray fiber diffraction, and biochemical studies.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1005973
- Journal Information:
- Proc. Natl. Acad. Sci. USA, Vol. 106, Issue (45) ; 11, 2009; ISSN 0027-8424
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
Proinsulin C-peptide interferes with insulin fibril formation